Amiodarone as a first choice drug

Trials, Sep 2000

Niall Mulvahill

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

http://www.trialsjournal.com/content/pdf/cvm-2001-72002.pdf

Amiodarone as a first choice drug

ArticleCopyright ArticleGrants : Biomed Central Ltd2001 : - ArticleHistory Niall Mulvahill,Aff1 Corresponding Affiliation: Aff1 Context Chronic atrial fibrillayion, class III drugs, medical cardioversion This paper describes a prospective randomised controlled study to assess the effectiveness of amiodarone in converting both short-term and long-lasting atrial fibrillation (AF) after 30 days of treatment. This research was undertaken because of conflicting reports on the effectiveness (16%-19%) of amiodarone in the conversion of A F. This study also mandated that amiodarone was used as first line drug treatment. Significant findings Overall, 80.5% of the amiodarone group and 40% of the placebo group converted to sinus rhythm at 30 days Comments I found this article interesting because of the high success rate of conversion to sinus rhythm with amiodarone treatment in patients with increased left atrial size (46 mm; 61%) and those with chronic AF (35%). In accordance with other reports the longer duration of amiodarone treatment is associated with higher conversion rates in patients with chronic AF. Possible implications of these findings are that prolonged use of amiodarone could be recommended in patients with dilated left atria and chronic AF after initial Failure of chemical cardioversion. For patients with recent onset AF with normal atrial size, the conversion rate to sinus rhythm with digoxin was >90%; suggesting that amiodarone is not necessary for the majority of this patient subgroup. Methods Patients received intravenous (24 h) followed by oral amiodarone or placebo. All patients received digoxin for the first 24 h. . Additional information This PDF file was created after publication. 1. Vardos PE , Kochiadakis GE , Igoumenidis NE , Tsatsakis AM , Simantriakis EN , Chlouverakis GI : Amiodarone as a first choice drug for restoring sinus rhythm in patients with atrial fibrillation . Chest . 2000 , 17 : 1538 - 1545 . (...truncated)


This is a preview of a remote PDF: http://www.trialsjournal.com/content/pdf/cvm-2001-72002.pdf

Niall Mulvahill. Amiodarone as a first choice drug, Trials, 2000, pp. 72002, 2,